InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,033.39
(
-3.54%
)
Post# of 252484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 17448
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: rkrw post# 64405

Friday, 07/18/2008 8:13:34 AM

Friday, July 18, 2008 8:13:34 AM

Post# of 252484
Re: BiovaxID

The trial design stated very clearly that the randomization was BEFORE the 6 month rest period.

It would seam to have made more sense to randomize at time of vaccination. My guess is they needed the time to produce the drug . Perhaps one of the trial experts could chirp in.

And ITT is INTENT To Treat, you must count the patients even if they drop out.

It will be tough to partner this drug. It (and the 2 other ID vaccine variations) are now 0-3 in P3 trials. BiovaxID proved near impossible to make. And I don't think the companies PR spin will help convince a potential partner.

I would guess yesterday's PR was to move the PPS for a finance deal.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up